![Margo Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Margo Roberts
Direttore/Membro del Consiglio presso
Appia Bio, Inc.
Profilo
Margo R.
Roberts currently works at Appia Bio, Inc., as Director from 2022.
Dr. Roberts also formerly worked at Cell Genesys, Inc., as Director-Immune & Cell Therapy from 1990 to 1998, Celyad Oncology SA, as Independent Director from 2018 to 2020, Unity Biotechnology, Inc., as Independent Director from 2018 to 2025, Instil Bio, Inc., as Director, the University of Virginia, as Associate Professor from 1999 to 2011, Yale University, as Principal, Kite Pharma, Inc., as Chief Scientific Officer & SVP-Discovery Research from 2011 to 2018, and Lyell Immunopharma, Inc., as Chief Scientific Officer from 2019 to 2021.
Dr. Roberts received her undergraduate degree and doctorate degree from the University of Leeds.
Posizioni attive di Margo Roberts
| Società | Posizione | Inizio |
|---|---|---|
Appia Bio, Inc.
 Appia Bio, Inc. BiotechnologyHealth Technology Develops cell therapies | Direttore/Membro del Consiglio | 09/08/2022 |
Precedenti posizioni note di Margo Roberts
| Società | Posizione | Fine |
|---|---|---|
| UNITY BIOTECHNOLOGY, INC. | Direttore/Membro del Consiglio | 27/06/2025 |
| LYELL IMMUNOPHARMA, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2021 |
| CELYAD ONCOLOGY SA | Direttore/Membro del Consiglio | 06/08/2020 |
| KITE PHARMA INC | Direttore Tecnico/Scientifico/R&S | 01/07/2018 |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/12/2011 |
Formazione di Margo Roberts
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
80
Relazioni di 1° grado
10
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 10 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
University of Virginia
University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celyad Oncology SA
 Celyad Oncology SA BiotechnologyHealth Technology Develops immuno-oncology and cardiology products | Health Technology |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Unity Biotechnology, Inc.
 Unity Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for osteoarthritis, eye and pulmonary diseases | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
Appia Bio, Inc.
Appia Bio, Inc. BiotechnologyHealth Technology Develops cell therapies | Health Technology |
